ask="5.15"
ask_size="100"
average_daily_volume="182087"
bid="2.70"
bid_size="400"
book_value="0.00"
change="-0.08"
change_from_200_day_moving_average="-0.83"
change_from_50_day_moving_average="-0.61"
change_from_52_week_high="-5.79"
change_From_52_week_low="0.88"
change_in_percent="-2.00%"
close="3.93"
dividend_pay_date="8/1/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.18"
ebitda="0.00"
eps_estimate_current_year="-3.64"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="N/A"
high="4.04"
high_52_weeks="9.72"
last_trade_date="3/15/2017"
last_trade_price="3.93"
last_trade_size="424"
last_trade_time="4:00pm"
low="3.74"
low_52_weeks="3.05"
market_capitalization="N/A"
moving_average_200_day="4.76"
moving_average_50_day="4.54"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="4.02"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.39%"
percent_change_from_50_day_moving_average="-13.41%"
percent_change_from_52_week_high="-59.57%"
percent_change_from_52_week_low="+28.85%"
previous_close="4.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CYCC"
volume="75800"
weeks_range_52="3.05 - 9.72"
